Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

NLSPW

NLS Pharmaceutics Ltd.

Healthcare · USD

Set alert

Price alert · NLSPW

All alert types
0.02 USD 0.00 0.00%
As of Oct 28, 2026

Day range unavailable

0.0179 52-week range 0.0179
YTD
0.00%
1 year
0.00%
Open
—
Prev close
0.0179
Mkt cap
7.43K
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
0.00
Beta
-0.52
Short ratio
0.00
Inst. own
0.00%
Dividend
0.00
Ex-div date
50-d avg
0.01222
200-d avg
0.02651
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for NLSPW has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-30.83 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.9×
FY 2017: -203×FY 2018: -3.5×FY 2019: -236×FY 2020: -196×FY 2021: -54.8×FY 2022: -61.4×FY 2023: -73.5×FY 2024: -0.8×FY 2025: -0.9×
FY 2017 5y median -54.8× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 1.0×
FY 2017: -176×FY 2018: -0.0×FY 2019: -209×FY 2020: -62.0×FY 2021: 1207×FY 2022: 310×FY 2023: -102×FY 2024: 1.1×FY 2025: 1.0×
FY 2017 5y median 1.1× FY 2025
P/FCF -2.6×
FY 2017: -251×FY 2018: -0.0×FY 2019: -6779×FY 2020: -764×FY 2021: -43.7×FY 2022: -73.2×FY 2023: -92.7×FY 2024: -0.4×FY 2025: -2.6×
FY 2017 5y median -43.7× FY 2025
EV/EBITDA -2.4×
FY 2017: -237×FY 2018: -2132×FY 2019: -278×FY 2020: 8.0×FY 2021: -54.8×FY 2022: -65.1×FY 2023: -76.2×FY 2024: 0.0×FY 2025: -2.4×
FY 2017 5y median -54.8× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -38.0%
FY 2017: -0.4%FY 2018: -14775.1%FY 2019: -0.0%FY 2020: -0.1%FY 2021: -2.3%FY 2022: -1.4%FY 2023: -1.1%FY 2024: -268.9%FY 2025: -38.0%
FY 2017 5y median -2.3% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -114.5%
FY 2017: 86.3%FY 2018: 0.1%FY 2019: 88.3%FY 2020: 31.9%FY 2021: -2202.5%FY 2022: -502.8%FY 2023: 137.8%FY 2024: -140.8%FY 2025: -114.5%
FY 2017 5y median -140.8% FY 2025
ROIC -32.5%
FY 2017: -443.8%FY 2018: 0.2%FY 2019: 158.5%FY 2020: 54.5%FY 2021: -352.9%FY 2022: -261.7%FY 2023: 266.0%FY 2024: -311.5%FY 2025: -32.5%
FY 2017 5y median -261.7% FY 2025
ROA -72.5%
FY 2017: -290.9%FY 2018: -3.5%FY 2019: -782.2%FY 2020: -236.2%FY 2021: -207.2%FY 2022: -177.8%FY 2023: -659.1%FY 2024: -88.7%FY 2025: -72.5%
FY 2017 5y median -177.8% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income 43.5%
FY 2017: 0.0%FY 2018: 99.9%FY 2019: -121593.5%FY 2020: 45.2%FY 2021: -415.8%FY 2022: -30.5%FY 2023: 23.7%FY 2024: 62.9%FY 2025: 43.5%
FY 2017 FY 2025
EPS (diluted) 91.8%
FY 2017: 0.0%FY 2018: -5687.7%FY 2019: 98.5%FY 2020: -20.4%FY 2021: -37.3%FY 2022: -3.7%FY 2023: 61.9%FY 2024: -721.9%FY 2025: 91.8%
FY 2017 FY 2025
Free Cash Flow 35.1%
FY 2017: 0.0%FY 2018: 49.7%FY 2019: 93.0%FY 2020: -283.9%FY 2021: -1953.2%FY 2022: 7.3%FY 2023: 30.2%FY 2024: 55.9%FY 2025: 35.1%
FY 2017 FY 2025

Financial Health

Current Ratio 0.8×
FY 2017: 2.3×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 2.4×FY 2022: 2.8×FY 2023: 0.2×FY 2024: 2.7×FY 2025: 0.8×
FY 2017 5y median 2.4× FY 2025
Quick Ratio 0.8×
FY 2017: 2.3×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 2.4×FY 2022: 2.8×FY 2023: 0.2×FY 2024: 2.7×FY 2025: 0.8×
FY 2017 5y median 2.4× FY 2025
Debt / Equity 0.0×
FY 2017: -1.1×FY 2018: -0.8×FY 2019: -0.1×FY 2020: -0.2×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -0.2×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 0.8×
FY 2017: -1.2×FY 2018: -2126×FY 2019: -0.1×FY 2020: 0.0×FY 2021: 0.5×FY 2022: 0.6×FY 2023: -0.1×FY 2024: 0.5×FY 2025: 0.8×
FY 2017 5y median 0.5× FY 2025
Interest Coverage -0.4×
FY 2017: -6.5×FY 2018: -3.2×FY 2019: -5.1×FY 2020: -9.8×FY 2021: -174×FY 2022: -153×FY 2023: -81.3×FY 2024: -29.2×FY 2025: -0.4×
FY 2017 5y median -81.3× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31